A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy.
首创的 ERK1/2 和 ERK5 选择性抑制剂采用单分子策略克服了耐药性
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02169-z
Xiao Huan, Wang Aoxue, Shuai Wen, Qian Yuping, Wu Chengyong, Wang Xin, Yang Panpan, Sun Qian, Wang Guan, Ouyang Liang, Sun Qiu